PTGER1 and cancer: Recent studies have highlighted the role of various prostanoid receptors in modulating inflammatory pathways, suggesting that dysregulation of PTGER1 could contribute to the tumor microenvironment's inflammatory state, potentially exacerbating cancer progression [10].